Though several methods have been developed to detect inflammasome activation by imaging caspase-1 and other mediators activity in vitro and in vivo, applications to detect NLRP3 inflammasomes in retinal diseases have been limited (30). The gene discussed is CASP1; the disease is Abnormal retinal morphology.